RadNet, Inc. (RDNT)
76.42
+0.38
(+0.50%)
USD |
NASDAQ |
Nov 13, 16:00
76.41
-0.01
(-0.01%)
After-Hours: 19:59
RadNet Enterprise Value : 7.758B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 7.758B |
| November 12, 2026 | 7.728B |
| November 11, 2026 | 7.889B |
| November 10, 2026 | 7.878B |
| November 09, 2026 | 7.913B |
| November 06, 2026 | 7.725B |
| November 05, 2026 | 7.884B |
| November 04, 2026 | 8.061B |
| November 03, 2026 | 7.503B |
| November 02, 2026 | 7.497B |
| October 30, 2026 | 7.528B |
| October 29, 2026 | 7.540B |
| October 28, 2026 | 7.532B |
| October 27, 2026 | 7.532B |
| October 26, 2026 | 7.257B |
| October 23, 2026 | 7.280B |
| October 22, 2026 | 7.273B |
| October 21, 2026 | 7.127B |
| October 20, 2026 | 7.225B |
| October 19, 2026 | 7.195B |
| October 16, 2026 | 7.158B |
| October 15, 2026 | 7.285B |
| October 14, 2026 | 7.187B |
| October 13, 2026 | 7.372B |
| October 12, 2026 | 7.370B |
| Date | Value |
|---|---|
| October 09, 2026 | 7.324B |
| October 08, 2026 | 7.112B |
| October 07, 2026 | 7.143B |
| October 06, 2026 | 7.275B |
| October 05, 2026 | 7.298B |
| October 02, 2026 | 7.247B |
| October 01, 2026 | 7.072B |
| September 30, 2026 | 7.169B |
| September 29, 2026 | 7.312B |
| September 28, 2026 | 7.403B |
| September 25, 2026 | 7.323B |
| September 24, 2026 | 7.364B |
| September 23, 2026 | 7.513B |
| September 22, 2026 | 7.570B |
| September 21, 2026 | 7.471B |
| September 18, 2026 | 7.733B |
| September 17, 2026 | 7.873B |
| September 16, 2026 | 7.716B |
| September 15, 2026 | 7.821B |
| September 14, 2026 | 7.693B |
| September 11, 2026 | 7.693B |
| September 10, 2026 | 7.598B |
| September 09, 2026 | 7.329B |
| September 08, 2026 | 7.416B |
| September 04, 2026 | 7.553B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Castle Biosciences, Inc. | 798.68M |
| Lumexa Imaging Holdings, Inc. | 2.310B |
| Quest Diagnostics, Inc. | 34.44B |
| Labcorp Holdings, Inc. | 36.61B |
| OPKO Health, Inc. | 1.321B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.15M |
| Revenue (Quarterly) | 638.26M |
| Total Expenses (Quarterly) | 634.10M |
| EPS Diluted (Quarterly) | 0.0524 |
| Gross Profit Margin (Quarterly) | 6.51% |
| Profit Margin (Quarterly) | 3.00% |
| Earnings Yield | -0.38% |
| Operating Earnings Yield | 1.88% |
| Normalized Earnings Yield | 0.0522 |